The Challenge
Healthcare systems worldwide are grappling with several critical challenges:
The Opportunity
Clinical Decision Support (CDS) Tools offer transformative solutions to address these challenges. CDS algorithms assist HCPs in making informed decisions about patient care. These algorithms analyse data from various sources, such as electronic medical records (EMR), patient data and medical literature, to provide actionable insights, recommendations, or alerts in real-time.
CDS algorithms can be broadly categorized into two groups:
How CDS Addresses Key Challenges
CDS Transforming Healthcare
By addressing these challenges, CDS algorithms have the potential to revolutionize healthcare delivery and achieve the dual goals of personalization and prevention.
Enabling Personalized Healthcare: CDS will be a critical lever for delivering on the industry´s vision for personalized healthcare. CDS tailors care by analysing the most up-to-date clinical data and a patient’s unique characteristics to recommend treatments with the highest efficacy and lowest risk of side effects.
Shifting to Preventative Care: Healthcare has long been criticized for its reactive, symptomatic approach to patient care. CDS tools can shift the paradigm from symptomatic to preventative care by predicting the likelihood of developing a disease based on patient-specific factors. Early detection and intervention become possible.
[1] NUS AI platform enables doctors to optimise personalised chemotherapy dose
Reimagining the NASH Patient Journey
Let´s use a real example to make the transformational potential of CDS more tangible!
Understanding NASH
Nonalcoholic Steatohepatitis (NASH) is a progressive liver disease marked by fat accumulation, inflammation, and fibrosis. It significantly increases the risk of cirrhosis, liver failure, and liver cancer. Despite decades of R&D efforts and substantial investment by the pharmaceutical industry, there remains significant unmet need in the disease. However, we are on the brink of a new era of hope for patients, with multiple promising late-stage therapies anticipated to reach the market soon.
Current NASH Patient Journey
Today, the journey of a NASH patient is fraught with pain points & challenges
Reimagining the NASH Patient Journey
Implementation of CDS use cases can revolutionize the management of NASH patients
(1) Screening
(2) Diagnosis
(3) Treatment
(4) Monitoring
So, who is this relevant to?
CDS will enable a paradigm shift in healthcare delivery and add tremendous value to the system. Health Technology, Pharmaceutical, Medical Technology, and Diagnostics companies are heavily investing in CDS development as a strategic priority. Their motivations include improving care delivery, optimizing patient management, and gaining a competitive edge in the rapidly evolving healthcare landscape.
While CDS tools are often monetized directly as standalone solutions, they also create significant value for Pharma and Medtech companies. Patient identification, treatment matching and treatment monitoring use cases help get more patients on treatment, faster and ensure optimal therapeutic outcomes. Its important to consider how CDS maps to your company´s strategy and the specific leverage points you are looking to address along the patient journey.
Stay tuned!
Stay tuned for our second white paper in this series – where we can help you decide if and how CDS solutions fit into your company’s strategy and key considerations for developing and scaling your CDS solution.
Rebecca Bub, Manager at Intellishore